For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well ...
Dosage and administration
Apply Uracin™ 10% cream to affected area(s) twice daily, or as directed by your licensed healthcare practitioner. Rub in until completely absorbed. Apply to diseased or damaged nail(s) twice daily, or as directed by a licensed healthcare practitioner.
Uracin
TM 10% Cream
is a keratolytic emollient which is a gentle, yet potent, tissue softener for nails and/or skin. Each gram contains 100 mg of urea in a vehicle consisting of the following inactive ingredients : Acrylamide/Sodium Acryloyldimethyltaurate Copolymer, Butyrospermum Parkii (Shea) Butter, Ceteareth-20, Cetearyl Alcohol, Citric Acid, Cocos Nucifera (Coconut) Oil, Dimethicone, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Helianthus Annuus (Sunflower) Seed Oil, Isohexadecane, PEG-100 Stearate, Phenoxyethanol, Polysorbate 80, Purified Water, Sorbitan Oleate, Xanthan Gum.
Urea is a diamide of carbonic acid with the following chemical structure:
Chemical Structure
CLINICAL PHARMACOLOGY
CLINICAL PHARMACOLOGY SECTION
Urea gently dissolves the intracellular matrix which results in loosening of the horny layer of the skin and shedding of scaly skin at regular intervals, thereby softening hyperkeratotic areas of the skin.
Pharmacokinetics
PHARMACOKINETICS SECTION
The mechanism of action of topically applied urea is not yet known.
INDICATIONS AND USAGE
INDICATIONS & USAGE SECTION
For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.
CONTRAINDICATIONS
CONTRAINDICATIONS SECTION
This product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.
WARNINGS
WARNINGS SECTION
FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
KEEP OUT OF REACH OF CHILDREN.
If swallowed, get medical help or contact a Poison Control Center right away.
Avoid contact with eyes, lips and mucous membranes.
General
GENERAL PRECAUTIONS SECTION
This product is to be used as directed by a licensed healthcare practitioner and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use and consult a licensed healthcare practitioner.
Information for Patients
INFORMATION FOR PATIENTS SECTION
Patients should discontinue the use of this product if the condition becomes worse or if a rash develops in the area being treated or elsewhere. Avoid contact with eyes, lips and mucous membranes. (See Warnings) for additional precautions.
Carcinogenesis, Mutagenesis and Impairment of Fertility:
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION
Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.
Pregnancy
PREGNANCY SECTION
Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.
Nursing Mothers
NURSING MOTHERS SECTION
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.
ADVERSE REACTIONS
ADVERSE REACTIONS SECTION
Transient stinging, burning, itching or irritation may occur and normally disappear upon discontinuing the use of this product.
To report SUSPECTED ADVERSE REACTIONS, contact
PureTek Corporation at
1-877-921-7873 or
FDA at
1-800-FDA-1088 or
www.fda.gov/medwatch.
DOSAGE AND ADMINISTRATION
DOSAGE & ADMINISTRATION SECTION
Apply Uracin™ 10% cream to affected area(s) twice daily, or as directed by your licensed healthcare practitioner. Rub in until completely absorbed. Apply to diseased or damaged nail(s) twice daily, or as directed by a licensed healthcare practitioner.
HOW SUPPLIED
HOW SUPPLIED SECTION
Uracin™ 10% cream is supplied in white plastic jars containing 8 oz (227 g) of cream, NDC 59088-256-16.
STORAGE
SAFE HANDLING WARNING SECTION
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Protect from freezing and excessive heat. Keep container tightly closed.
Uracin™ 10% Cream
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Manufactured by:
PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free:
1-877-921-7873
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.